12 results on '"Iov, Diana-Elena"'
Search Results
2. Gastro-Esophageal Reflux Disease and Paroxysmal Atrial Fibrillation Ablation.
- Author
-
Floria, Mariana, Iov, Diana-Elena, Tanase, Daniela Maria, Barboi, Oana Bogdana, Baroi, Genoveva Livia, Burlacu, Alexandru, Grecu, Mihaela, Sascau, Radu Andy, Statescu, Cristian, Mihai, Catalina, and Drug, Vasile Liviu
- Subjects
- *
GASTROESOPHAGEAL reflux , *ATRIAL flutter , *ATRIAL fibrillation , *BODY mass index - Abstract
Patients undergoing ablation for atrial fibrillation may be at increased risk of developing gastroesophageal reflux disease. We prospectively studied the presence of symptomatic gastroesophageal reflux disease in naïve patients who underwent atrial fibrillation ablation. Methods: The presence of typical symptoms suggestive of gastroesophageal reflux disease was clinically assessed by the gastroenterologist at baseline and at 3 months after ablation. In addition to that, all patients underwent upper gastrointestinal endoscopy. Results: Seventy-five patients were included in two groups: 46 patients who underwent atrial fibrillation ablation (study group) and 29 patients without ablation (control group). Patients with atrial fibrillation ablation were younger (57.76 ± 7.66 years versus 67.81 ± 8.52 years; p = 0.001), predominantly male (62.2% versus 33.3%; p = 0.030) and with higher body mass index (28.96 ± 3.12 kg/m2 versus 26.81 ± 5.19 kg/m2; p = 0.046). At three months after the ablation, in the study and control groups, there were 88.9% and 57.1% patients in sinus rhythm, respectively, (p = 0.009). Symptomatic gastroesophageal reflux disease was not more frequent in the study group (42.2% versus 61.9%; p = 0.220). There was no difference in terms of sinus rhythm prevalence in patients with versus without symptomatic gastroesophageal reflux disease (89.5% versus 88.5%; p = 0.709). Conclusion: In this small prospective study, typical symptoms suggestive of gastroesophageal reflux disease were not more frequent three months following atrial fibrillation ablation. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
3. Pepsin and the Lung—Exploring the Relationship between Micro-Aspiration and Respiratory Manifestations of Gastroesophageal Reflux Disease.
- Author
-
Iov, Diana-Elena, Bărboi, Oana-Bogdana, Floria, Mariana, Neamțu, Andrei, Iliescu, Radu, and Drug, Vasile-Liviu
- Subjects
- *
LUNGS , *GASTROESOPHAGEAL reflux , *PEPSIN , *CHRONIC obstructive pulmonary disease , *ASTHMA , *SYMPTOMS - Abstract
Gastroesophageal reflux disease (GERD) is one of the most commonly encountered disorders in clinical practice nowadays, with an increasing burden on healthcare systems worldwide. GERD-related respiratory symptoms such as unexplained chronic cough, bronchial asthma or chronic obstructive pulmonary disease (COPD) with frequent exacerbations often pose diagnostic and therapeutic challenges and may require a multidisciplinary approach. Moreover, a potential role of GERD as a risk factor has been proposed for chronic rejection in patients who underwent lung transplantation. Pepsin has gained considerable attention from the scientific community in the last few years as a possible surrogate biomarker for GERD. The aim of this narrative review was to provide an overview of the potential utility of pepsin detection as a marker of micro-aspiration in various biological fluids retrieved from patients with suspected GERD-induced respiratory manifestations and in lung transplant patients with allograft dysfunction. Data on the subject remains highly contradictory, and while certain studies support its applicability in investigating atypical GERD manifestations, at the moment, it would be realistic to accept a modest utility at best. A major lack of consensus persists regarding topics such as the optimal timeframe for fluid collection and cut-off values. Further research is warranted in order to address these issues. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
4. Tricuspid valve prosthesis dysfunction revisited.
- Author
-
Floria, Mariana, Mihailov, Liliana, and Iov, Diana‐Elena
- Subjects
- *
HEART beat , *BIOPROSTHETIC heart valves , *DOPPLER echocardiography , *TRICUSPID valve diseases , *SENSITIVITY & specificity (Statistics) - Abstract
The article explores current recommendations and challenges in managing dysfunction of tricuspid valve (TV) prostheses. It emphasizes the prevalence of repair over replacement in TV procedures, particularly in bioprosthetic valves, highlighting factors like pannus formation and structural deterioration as significant causes of dysfunction.
- Published
- 2024
- Full Text
- View/download PDF
5. Mitral Annular Calcification and Thromboembolic Risk.
- Author
-
Morariu, Paula Cristina, Tanase, Daniela Maria, Iov, Diana Elena, Sîrbu, Oana, Oancea, Alexandru Florinel, Mircea, Cornel Gabriel, Chiriac, Cristina Petronela, Baroi, Genoveva Livia, Morariu, Ionela-Daniela, Dascălu, Cristina Gena, Şorodoc, Laurenţiu, and Floria, Mariana
- Subjects
- *
DISEASE risk factors , *THROMBOEMBOLISM , *CALCIFICATION , *TYPE 2 diabetes , *VENTRICULAR ejection fraction , *VASCULAR diseases , *CALCIFICATIONS of the breast - Abstract
Thromboembolic (TE) risk scores used for atrial fibrillation (AF) patients do not include mitral annular calcification (MAC) as a potential indicator of vascular disease. This research evaluated the correlation between MAC and TE risk scores (CHADS2 and CHA2DS2-VASc). We compared TE risk score values and clinical and echocardiographic data in patients with and without MAC. We included, prospectively, 103 patients: 40.8% with AF, 83.5% with hypertension, 30.1% with type II diabetes mellitus, 79.6% with chronic heart failure, and 7.8% with a history of stroke. We identified MAC in 50.5% of patients. The mean CHADS2 and CHA2DS2-VASc scores were 2.56 ± 1.135 and 4.57 ± 1.61, respectively. In MAC patients, both scores tended to increase significantly compared with the control (2.88 ± 1.114 versus 2.24 ± 1.06, p = 0.005, and 5.21 ± 1.51 versus 3.92 ± 1.46, p < 0.001, respectively). The left ventricular ejection fraction negatively correlated with the presence of MAC (r = −0.254, p = 0.01). The presence of MAC was a risk factor for vascular disease (OR = 2.47, χ2 = 34.32, p < 0001). Conclusions: The presence of MAC is associated with greater TE risk scores and a higher risk of vascular disease. It appears that adding MAC as a vascular disease parameter to TE risk scores may have benefits for patients by improving their predictive value. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. Subclinical right ventricular dysfunction diagnosis in systemic sclerosis.
- Author
-
Floria, Mariana, Mihailov, Liliana, and Iov, Diana‐Elena
- Subjects
- *
PULMONARY hypertension diagnosis , *TRICUSPID valve , *VENTRICULAR ejection fraction , *PULMONARY hypertension , *DILATATION & curettage , *MAGNETIC resonance imaging , *SYSTEMIC scleroderma , *DOPPLER echocardiography , *RIGHT ventricular dysfunction , *ECHOCARDIOGRAPHY , *CARDIAC catheterization , *DISEASE complications - Abstract
An editorial addresses subclinical right ventricular (RV) dysfunction diagnosis in systemic sclerosis (SSc), focusing on pulmonary hypertension (PH) as a major complication. It highlights the role of echocardiography in detecting early signs of RV dysfunction and PH, using parameters like tricuspid annular plane systolic excursion (TAPSE) and tricuspid regurgitation velocity (TRV).
- Published
- 2024
- Full Text
- View/download PDF
7. Hereditary Hemorrhagic Telangiectasia and Arterio-Venous Malformations—From Diagnosis to Therapeutic Challenges.
- Author
-
Floria, Mariana, Năfureanu, Elena Diana, Iov, Diana-Elena, Sîrbu, Oana, Dranga, Mihaela, Ouatu, Anca, Tănase, Daniela Maria, Bărboi, Oana Bogdana, Drug, Vasile Liviu, and Cobzeanu, Mihail Dan
- Subjects
- *
BRAIN abscess , *HEREDITARY hemorrhagic telangiectasia , *TRANSIENT ischemic attack , *HUMAN abnormalities , *PARADOXICAL embolism , *MINIMALLY invasive procedures , *NASAL mucosa - Abstract
Hereditary hemorrhagic telangiectasia is a rare autosomal dominant vascular disease defined by the presence of mucosal and cutaneous telangiectasia and visceral arterio-venous malformations. The latter are abnormal capillary-free direct communications between the pulmonary and systemic circulations with the following consequences: arterial hypoxemia caused by right-to-left shunts; paradoxical embolism with transient ischemic attack or stroke and brain abscess caused by the absence of the normally filtering capillary bed; and hemoptysis or hemothorax due to the rupture of the thin-walled arterio-venous malformations (particularly during pregnancy). It is frequently underdiagnosed, commonly presenting as complications from shunting through arterio-venous malformations: dyspnea, chronic bleeding, or embolism. Arterio-venous malformations are present not only in the lungs, but can also be found in the liver, central nervous system (mainly in the brain), nasal mucosa, or the gastrointestinal tract. The first choice of therapy is embolization of the afferent arteries of the arterio-venous malformations, a minimally invasive procedure with a high efficacy, a low morbidity, and low mortality. Other therapeutic modalities are surgery (resection) or stereotactic radiosurgery (using radiation). Routine screening for arterio-venous malformations is indicated in patients diagnosed with this condition and can prevent severe complications such as acute hemorrhages, brain abscesses, or strokes. Clinicians should provide a long-term follow-up for patients with arterio-venous malformations, in an effort to detect their growth or reperfusion in case of previously treated malformations. In spite of two experts' consensuses, it still possesses multiple therapeutic challenges for physicians, as several aspects regarding the screening and management of arterio-venous malformations still remain controversial. Multidisciplinary teams are especially useful in complex cases. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
8. An Overview of the Pharmacokinetics and Pharmacodynamics of Landiolol (an Ultra-Short Acting β1 Selective Antagonist) in Atrial Fibrillation.
- Author
-
Floria, Mariana, Oancea, Alexandru Florinel, Morariu, Paula Cristina, Burlacu, Alexandru, Iov, Diana Elena, Chiriac, Cristina Petronela, Baroi, Genoveva Livia, Stafie, Celina Silvia, Cuciureanu, Magdalena, Scripcariu, Viorel, and Tanase, Daniela Maria
- Subjects
- *
ATRIAL fibrillation , *HEART beat , *PHARMACOKINETICS , *PHARMACODYNAMICS , *CHILD patients , *ARRHYTHMIA - Abstract
Landiolol is an ultra-short-acting, selective β1-adrenergic receptor blocker that was originally approved in Japan for the treatment of intraoperative tachyarrhythmias. It has gained attention for its use in the management of tachyarrhythmias and perioperative tachycardia, especially atrial fibrillation for both cardiac and non-cardiac surgeries. It can be the ideal agent for heart rate control due to its high β1-selectivity, potent negative chronotropic effect, a limited negative inotropic potential, and an ultrashort elimination half-life (around 4 min); moreover, it may have a potential therapeutic effects for sepsis and pediatric patients. Landiolol seems to be superior to other short-acting and selective beta-blockers such as esmolol. This review aims to provide a comprehensive overview of landiolol, a new ultra-short-acting β1 selective antagonist, including its pharmacology, clinical applications, efficacy, safety profile, and future directions in research and clinical data. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Multimodality Imaging in Right Heart Tumors: Proposed Algorithm towards an Appropriate Diagnosis.
- Author
-
Floria, Mariana, Burlacu, Alexandru, Morariu, Paula Cristina, Oancea, Alexandru-Florinel, Iov, Diana-Elena, Baroi, Genoveva Livia, Stafie, Celina Silvia, Scripcariu, Viorel, and Tănase, Daniela Maria
- Subjects
- *
HEART tumors , *CARDIAC imaging , *DIAGNOSIS , *POSITRON emission tomography , *CARDIAC magnetic resonance imaging - Abstract
A right heart tumor can be identified by transthoracic echocardiography during a routine examination or due to cardiac symptoms. The first step is the assessment by echocardiography, with its multiple techniques, and the obtained information must be judged in a clinical and biological context. The second step comprises one, sometimes even two, of the more complex modality imaging methods. The choice is driven not only by the advantages of each imaging technique but also by local expertise or the preferred imaging modality in the center. This step is followed by staging, follow-up, and/or imaging-guided excision or biopsy, which is performed in selected cases in order to obtain anatomopathological confirmation. In the presence of features suggestive of malignancy or causing hemodynamic impairment, a transvenous biopsy is essential before the more complex imaging modalities (which are still relevant in the staging process). Using a structured imaging approach, it is possible to reach an appropriate diagnosis without a biopsy. Frequently, these imaging techniques have a complementary role, so an integrated imaging approach is recommended. This proposed algorithm for appropriate diagnosis of right heart tumors could serve as a practical guide for clinicians (not only imaging specialists). [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. The Potential Use of Artificial Intelligence in Irritable Bowel Syndrome Management.
- Author
-
Vulpoi, Radu Alexandru, Luca, Mihaela, Ciobanu, Adrian, Olteanu, Andrei, Bărboi, Oana, Iov, Diana-Elena, Nichita, Loredana, Ciortescu, Irina, Cijevschi Prelipcean, Cristina, Ștefănescu, Gabriela, Mihai, Cătălina, and Drug, Vasile Liviu
- Subjects
- *
IRRITABLE colon , *ARTIFICIAL intelligence , *LARGE intestine , *MOBILE apps - Abstract
Irritable bowel syndrome (IBS) has a global prevalence of around 4.1% and is associated with a low quality of life and increased healthcare costs. Current guidelines recommend that IBS is diagnosed using the symptom-based Rome IV criteria. Despite this, when patients seek medical attention, they are usually over-investigated. This issue might be resolved by novel technologies in medicine, such as the use of Artificial Intelligence (AI). In this context, this paper aims to review AI applications in IBS. AI in colonoscopy proved to be useful in organic lesion detection and diagnosis and in objectively assessing the quality of the procedure. Only a recently published study talked about the potential of AI-colonoscopy in IBS. AI was also used to study biofilm characteristics in the large bowel and establish a potential relationship with IBS. Moreover, an AI algorithm was developed in order to correlate specific bowel sounds with IBS. In addition to that, AI-based smartphone applications have been developed to facilitate the monitoring of IBS symptoms. From a therapeutic standpoint, an AI system was created to recommend specific diets based on an individual's microbiota. In conclusion, future IBS diagnosis and treatment may benefit from AI. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
11. Atrial Fibrillation and Chronic Coronary Ischemia: A Challenging Vicious Circle.
- Author
-
Oancea, Alexandru Florinel, Jigoranu, Raul Alexandru, Morariu, Paula Cristina, Miftode, Radu-Stefan, Trandabat, Bogdan Andrei, Iov, Diana Elena, Cojocaru, Elena, Costache, Irina Iuliana, Baroi, Livia Genoveva, Timofte, Daniel Vasile, Tanase, Daniela Maria, and Floria, Mariana
- Subjects
- *
ARRHYTHMIA , *ATRIAL fibrillation , *TYPE 2 diabetes , *ACTION potentials , *FIBRINOLYTIC agents , *ISCHEMIA , *GTPASE-activating protein - Abstract
Atrial fibrillation, the most frequent arrhythmia in clinical practice and chronic coronary syndrome, is one of the forms of coronary ischemia to have a strong dual relationship. Atrial fibrillation may accelerate atherosclerosis and may increase oxygen consumption in the myocardium, creating a mismatch between supply and demand, thus promoting the development or worsening of coronary ischemia. Chronic coronary syndrome alters the structure and function of gap junction proteins, affecting the conduction of action potential and leading to ischemic necrosis of cardiomyocytes and their replacement with fibrous tissue, in this way sustaining the focal ectopic activity in atrial myocardium. They have many risk factors in common, such as hypertension, obesity, type 2 diabetes mellitus, and dyslipidemia. It is vital for the prognosis of patients to break this vicious circle by controlling risk factors, drug therapies, of which antithrombotic therapy may sometimes be challenging in terms of prothrombotic and bleeding risk, and interventional therapies (revascularization and catheter ablation). [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
12. COMBINED PH-IMPEDANCE MONITORING - A NECESSARRY TOOL FOR THE GASTROINTESTINAL FUNCTIONAL UNIT.
- Author
-
Barboi, Oana-Bogdana, Petrea, Oana-Cristina, Vulpoi, Radu-Alexandru, Iov, Diana-Elena, Trifan, Anca, and Drug, Vasile-Liviu
- Subjects
- *
HEARTBURN , *CHEST pain , *CHRONIC cough , *PROTON pump inhibitors , *GASTROESOPHAGEAL reflux , *ASTHMA , *ALIMENTARY canal - Abstract
Introduction. Multichannel intraluminal esophageal impedance combined to pH-metry (pH-MII) is a sensitive tool for evaluating gastroesophageal reflux disease (GERD). The impedance-pH monitoring diagnostic test determines the frequency of reflux episodes (both acid or nonacid and liquid, gas or mixed) and the time relationship of reflux episodes and symptoms. Extradigestive manifestations and refractory GERD are two of the main recommendations for the assessment of upper digestive tract by pH-MII. Material and method. We conducted a prospective study between January 2022 - March 2023 at our tertiary referral center in North-Eastern Romania that included 26 patients suspected of GERD. All patients were investigated through pHMII. We used a ZepHr® system from Sandhill Scientific and single-use catheters with one pH electrode and 6 impedance electrodes. Patients who underwent MII-pH testing for refractory GERD were tested on proton pump inhibitor (PPI), while patients with no previous evidence of GERD were assessed off PPI. The diagnosis of GERD and phenotypes were based on Lyon metrics. Results. Out of the 26 patients, 14 (53.8%) were male and 12 (46.2%) female, with a mean age of 48.6±13.5 years. Nineteen patients (73.07%) presented with extradigestive GERD symptoms, of whom 7 patients (36.8%) with chronic cough, 7 patients (36.8%) with chronic laryngitis, 4 patients (21.05%) with non-cardiac chest pain and 1 patient (5.26%) with bronchial asthma. The rest of 7 (26.92%) patients were investigated for refractory GERD. After the final analysis of pH-MII tracks, we found GERD in 10 (38.5%) patients, functional heartburn in 6 (23.1%) patients and hypersensitive esophagus in 3 (15.4%) patients. All the 10 patients diagnosed with GERD had acid reflux, with a mean DeMeester Score of 46.7±83.8 and a mean AET of 12.8±20.9%. The mean total number of GERD episodes was 100.3±7.5 and the mean longest reflux episode was of 53.7±85.7 minutes. Conclusion. Multichannel intraluminal esophageal impedance combined to pH-metry represents an important instrument for assessing extradigestive GERD and refractory GERD. [ABSTRACT FROM AUTHOR]
- Published
- 2023
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.